Dongke Yu

1.5k total citations
44 papers, 1.1k citations indexed

About

Dongke Yu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Dongke Yu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Dongke Yu's work include Liver physiology and pathology (4 papers), Gut microbiota and health (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Dongke Yu is often cited by papers focused on Liver physiology and pathology (4 papers), Gut microbiota and health (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Dongke Yu collaborates with scholars based in China, United States and Ireland. Dongke Yu's co-authors include Junrong Du, Xueqin Yang, Hui Li, Xue Li, Rong‐Guang Shao, Hongwei He, Jianyou Shi, Shi‐Ying Cai, Cai‐Xia Zhang and Rongsheng Tong and has published in prestigious journals such as The Science of The Total Environment, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Dongke Yu

42 papers receiving 1.1k citations

Peers

Countries citing papers authored by Dongke Yu

Since Specialization

Citations

This map shows the geographic impact of Dongke Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongke Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongke Yu more than expected).

Fields of papers citing papers by Dongke Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongke Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongke Yu. The network helps show where Dongke Yu may publish in the future.

Co-authorship network of co-authors of Dongke Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongke Yu. A scholar is included among the top collaborators of Dongke Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongke Yu. Dongke Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel phosphodiesterase 4/5 dual-target inhibitor ameliorates neuroinflammation via the NF-κB and JNK pathway 2025 ·International Journal of Biological Macromolecules ·Liyun Zhao, Wenjie Jiang, Yingying Cao, Yi‐You Huang, Xue Wang, (unknown), Dongke Yu, Jianyou Shi	0
2	Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure–activity relationship 2023 ·Bioorganic Chemistry ·(unknown), Zhengjie Zhang, Dongke Yu, (unknown), Ling Li, (unknown), Jianyou Shi	7
3	Dissecting the multifaced function of transcription factor EB (TFEB) in human diseases: From molecular mechanism to pharmacological modulation 2023 ·Biochemical Pharmacology ·Lijuan Zhang, Zhijia Li, Lan Zhang, Yuan Qin, Dongke Yu	5
4	Genistein protects benzotriazole ultraviolet stabilizer UV-234-induced hepatotoxicity by modulating ROS/Nrf2 and NF-κB signaling in yellow catfish (Pelteobagrus fulvidraco) 2023 ·Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·Siwen Li, Jiaqi Xie, Xinlian Li, Qiuyue Li, Xiao‐Qing Tang, Dongke Yu, (unknown)	5
5	Potential therapeutic medicines for renal fibrosis: Small-molecule compounds and natural products 2023 ·Bioorganic Chemistry ·Xiang Yu, (unknown), (unknown), Linshen Xie, Dongke Yu, Jianyou Shi	6
6	Research progress of NLRP3 inflammasome and its inhibitors with aging diseases 2023 ·European Journal of Pharmacology ·(unknown), Dongke Yu, (unknown), (unknown), Chun Guo, Jianyou Shi	15
7	Dual properties of pharmacological activities and preparation excipient: Bletilla striata polysaccharides 2023 ·International Journal of Biological Macromolecules ·Lan Bai, Ting Wang, (unknown), Wei Zheng, (unknown), (unknown), Rongsheng Tong, Dongke Yu, Jianyou Shi	29
8	Triclocarban evoked neutrophil extracellular trap formation in common carp (Cyprinus carpio L.) by modulating SIRT3-mediated ROS crosstalk with ERK1/2/p38 signaling 2022 ·Fish & Shellfish Immunology ·Siwen Li, Yanling Wang, Dongke Yu, Yuan Zhang, Xiali Wang, Mei Shi, (unknown), Xinlian Li, Hongtao Xiao, Lu Chen, (unknown)	3
9	Advances in RIPK1 kinase inhibitors 2022 ·Frontiers in Pharmacology ·Lu Chen, Xiaoqin Zhang, (unknown), (unknown), Dongke Yu, (unknown), Lihong Niu, Lijuan Zhang, Jianyou Shi	31
10	Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA)-mediated ER stress crosstalk with autophagy is involved in tris(2-chloroethyl) phosphate stress-induced cardiac fibrosis 2022 ·Journal of Inorganic Biochemistry ·(unknown), Xiaoqin Zhang, Yuan Zhang, Jiaqi Xie, Yuan Bian, (unknown), Rongsheng Tong, Dongke Yu, Lingai Pan	10
11	Association between CYP2B6 c.516G >T variant and acute leukaemia 2021 ·Medicine ·(unknown), Dongke Yu, (unknown), Yuan Zhang, (unknown), Xiaotao Chen, Hongtao Xiao, Rongsheng Tong	1
12	Chronic periodontitis induces microbiota-gut-brain axis disorders and cognitive impairment in mice 2020 ·Experimental Neurology ·(unknown), Xiao Zou, Xueqin Yang, Peng Fu, Dongke Yu, Junrong Du	61
13	Probiotics modulate the microbiota–gut–brain axis and improve memory deficits in aged SAMP8 mice 2019 ·Acta Pharmaceutica Sinica B ·Xueqin Yang, Dongke Yu, Xue Li, Hui Li, Junrong Du	309
14	Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985) 2019 ·European Journal of Medicinal Chemistry ·(unknown), Dandan Guo, Zhongliang Jiang, Rongsheng Tong, Peidu Jiang, Lan Bai, Lu Chen, Yuxuan Zhu, Chun Guo, Jianyou Shi, Dongke Yu	120
15	Systematic Review and Meta-Analysis of the Efficacy and Safety of Telavancin for Treatment of Infectious Disease: Are We Clearer? 2016 ·Frontiers in Pharmacology ·Junlan Chuan, Yuan Zhang, Xia He, Yuxuan Zhu, Lei Zhong, Dongke Yu, Hongtao Xiao	8
16	RasGAP-derived peptide GAP159 enhances cisplatin-induced cytotoxicity and apoptosis in HCT116 cells 2014 ·Acta Pharmaceutica Sinica B ·Hao Zhang, Shenghua Zhang, Hongwei He, Caixia Zhang, Yi Chen, Dongke Yu, Jianhua Chen, Rong‐Guang Shao	7
17	Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway 2013 ·Molecular Carcinogenesis ·Yi Chen, Dongke Yu, Caixia Zhang, (unknown), Hongwei He, Jinjing Chen, Hao Zhang, Wuli Zhao, Zhen Wang, Xiaoyu Xu, Yong‐Su Zhen, Rong‐Guang Shao	19
18	The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells 2013 ·Biochemical and Biophysical Research Communications ·Cai‐Xia Zhang, Hong-Wei He, Hao Zhang, Dongke Yu, Wuli Zhao, Yi Chen, Rong‐Guang Shao	21
19	Design, synthesis and anticancer activity of 1-acyl-3-amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Dongke Yu, Juxian Wang, Hao Zhang, Hongwei He, Rong‐Guang Shao, Xuemei Li, Yucheng Wang	15
20	CD133⁺EpCAM⁺ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells 2012 ·International Journal of Biological Sciences ·Yi Chen, Dongke Yu, Hao Zhang, Hongwei He, Cai‐Xia Zhang, Wuli Zhao, Rong‐Guang Shao	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact